Zurich – MYNERVA has won the Grand Prize in the start-up competition venture. The company has developed stockings that use artificial intelligence and electrical impulses to prevent people with diabetic neuropathy from falling and relieve pain. Nerai Bio won the audience award.
(CONNECT) MYNERVA AG has won the Grand Prix of the venture Award 2025 for its medical device Leia. According to a press release, a total of 18 start-ups in six sectors came out on top among the record number of 396 submissions. Three innovations were presented in each of the categories Health & Nutrition, Finance & Insurance, ICT, Industry & Engineering, Retail & Consumer Services and Social & Environment.
“These visionary start-ups have not only impressed our advisory board, but also the mentors and jurors who have accompanied them every step of the way,” reads a statement from venture. The joint initiative of the Swiss Federal Institutes of Technology in Zurich (ETH) and Lausanne (EPFL), McKinsey & Company, Knecht Holding and Innosuisse is managed by the venture foundation.
Founded in 2025 and led by Greta Peatoni as CEO, the Zurich-based start-up MYNERVA, a spin-off from ETH Zurich, has spent five years of research developing Leia: a neuroprosthetic knee stocking that combines artificial intelligence and non-invasive electrical impulses to provide gentle and comfortable nerve stimulation, relieve pain and improve stability and mobility in diabetic neuropathy. It restores the sense of touch in those affected.
The winner of the audience award is Nerai Bioscience AG. The biotech start-up, also based in Zurich and founded in 2025, specializes in protein engineering for rare liver and eye diseases with its artificial intelligence-based platform Morpheme. ce/mm
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information